
Company Legal Name
Latest Valuation
Founded Year
Headquarter
Premialab operates an analytics platform designed specifically for institutional investors managing quantitative and multi-asset investment strategies. Based in Hong Kong, the company provides sophisticated analytical tools that enable institutional clients to optimize their investment decision-making processes across diverse asset classes. The platform addresses the growing complexity of modern portfolio management by delivering quantitative insights and data-driven solutions tailored to institutional requirements. Premialab's Hong Kong headquarters positions the company strategically within Asia's financial hub, allowing it to serve the region's expanding institutional investment community. The company continues to focus on enhancing its analytical capabilities to meet evolving institutional investor needs.

Available in most regions; subject to local regulations.
Open to non-accredited investors with KYC/AML compliance. U.S. investors must meet SEC requirements.
$10 per token, enabling fractionalized access to Pre-IPO shares.
Mandatory identity (KYC) and proof of funds checks.
Variable, applied to investment amounts.
Charged on realized profits.

Tokens may be locked for 6–12 months; resale depends on secondary market liquidity.
Prices reflect past funding rounds, not guaranteed future value.
Biotech depends on regulatory approvals; fintech faces evolving digital asset rules.
Blockchain or custodian issues could delay transfers or verification.
Changing laws may affect tradability or taxation.


